ClinicalRM Awarded Omnibus III Contracts to Support the Navy Medical Research Center (NMRC)
HINCKLEY, Ohio, Sept. 29, 2011 /PRNewswire/ -- Clinical Research Management, (ClinicalRM) a full-service Contract Research Organization providing services for basic and applied research, clinical trials, and regulatory support, announced today it was awarded two contracts by the Navy Medical Research Center (NMRC) under its Omnibus III program. The awards are for the provision resources in support of NMRC, including: providing an infrastructure of personnel, materials, equipment, facilities, science, and technology that will sustain an acceptable level of medical research.
ClinicalRM is one of only five other companies to be awarded contracts in both the Full & Open lot (W911QY-11-D-0051), which consists of 14 awardees, and the Small Business Set-Aside lot (W911QY-11-D-0065), which consists of 12 awardees. The contract ceiling for the 5 year Omnibus II program for all awardees is $497 M. The Omnibus III contract is an Indefinite Delivery/Indefinite Quantity (ID/IQ) contract.
The Omnibus III contract was issued with the intent of facilitating NMRC's mission to conduct R&D across its enterprise, including commands the Navy reports to or supports such as OASD-Health Affairs, JTF, CapMed, and more. Other branches of the Government will be able to use the contract with approval of the Contracting Office.
"We have a history of providing similar basic and applied biomedical and clinical research expertise to other areas of the government and are extremely pleased to be part of this award to extend our support to the Navy. Our company's priority is to improve the health and safety of our warfighters and their families through leading medical research," said Victoria Tifft, founder and CEO of ClinicalRM. Said Tifft, "For 18 years we've proven ourselves as trusted and innovative partners to the U.S. Armed Forces research initiatives, and we look forward to extending that relationship within the Navy Medical Research Center."
Performance under the Omnibus III contract is expected to begin after the new fiscal year starts.
About the Omnibus III Program
The Omnibus III requirement is to put in place personnel and process infrastructure that will facilitate Navy Medicine's mission to conduct Research & Development (R&D) across its enterprise, including commands that the Navy reports to or supports (e.g., OASD-Health Affairs, JTF CapMed, etc.). In addition to providing personnel, materials, equipment, and facilities (non-construction (bonded), non-Government spaces), this requirement addresses process infrastructure (such as basic university research, vaccine development, clinical trials, or FDA IND application processing).
Navy Medicine provides high quality, economical health care to beneficiaries in wartime and in peacetime. Highly trained Navy Medicine personnel deploy with Sailors and Marines worldwide – providing critical mission support aboard ship, in the air, and on the battlefield. At the same time, Navy Medicine's military and civilian health care professionals are providing care for uniformed services' family members and retirees at military treatment facilities around the globe.
Founded in 1992, ClinicalRM is a full service Contract Research Organization (CRO) specializing in preclinical, and Phase I to Phase IV clinical research, clinical trial support, and product development for biologics, drugs, and devices. ClinicalRM prides itself on providing outstanding customer service and exceeding client expectations.
ClinicalRM supports its clients with a wide array of regulatory and sponsor services including program and project management, site selection and management, recruitment, clinical data management, safety oversight, statistical analysis and reporting, training, and education within the U.S. and around the globe. Our commercial, military, Federal and academic customers include: academic research institutions, NIH, Walter Reed Army Institute of Research, U.S. Army Medical Materiel Development Activity, U.S. Army Medical Research Institute of Infectious Diseases, and the Naval Medical Research Center. For more information, please go to: www.clinicalrm.com